Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
2023 Q4
6 of 25 quarters
Total Value
$261.0K
Total Shares
7.1K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$261.0K
7.1K
0.0%
Unchanged
Bridgewater Associates LP
$261.0K
7.1K shares
Unchanged
HALO — Halozyme Therapeutics Inc - FilingSpy